✦ LIBER ✦

Are Patients with Esophageal Cancer Who Become PET Negative after Neoadjuvant Chemoradiation Free of Cancer?

✍ Scribed by James M. McLoughlin; Marcovalerio Melis; Erin M. Siegel; E. Michelle Dean; Jill M. Weber; Jeannie Chern; Melanie Elliott; Scott T. Kelley; Richard C. Karl

Book ID: 113678359
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 118 KB
Volume: 206
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2007.12.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival outcomes of resected patients w

Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer

✍ Z. T. Hammoud; K. A. Kesler; M. K. Ferguson; R. J. Battafarrano; A. Bhogaraju; N 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Changes of Pulmonary Fluorodeoxyglucose

Changes of Pulmonary Fluorodeoxyglucose Uptake After Neoadjuvant Concurrent Chemoradiation in Predicting Postoperative Pulmonary Complications for Patients With Esophageal Cancer

✍ Hsu, F.; Cheng, J.; Lee, J.; Huang, P.; Hsu, C.; Lin, C.; Tsai, Y.; Tzen, K.; Ye 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Long-term Outcome and Patterns of Failur

Long-term Outcome and Patterns of Failure after Neoadjuvant, Adjuvant and Definitive Chemoradiation in 340 Patients with Locally Advanced Esophageal Cancer

✍ F.P. Kong; L. Sun; R. Reddy; M. Schipper; S. Urba; A. Chang; J. Lin; X. Meng; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Recurrence after neoadjuvant chemoradiat

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

✍ Robert A. Meguid; Craig M. Hooker; Joshua T. Taylor; Laurence R. Kleinberg; Step 📂 Article 📅 2009 🏛 CTSNet 🌐 English ⚖ 132 KB

Quantified pathologic response assessed

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

✍ Agarwal, Atin; Chang, George J.; Hu, Chung-Yuan; Taggart, Melissa; Rashid, Asif; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Serum Vascular Endothelial Growth Factor

Serum Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Can Predict Pathological Response and Disease-Free Survival of Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy

✍ Chiang, Y.; Cheng, J.; Graber, M.; Hsu, F.; Tsai, C.; Lee, J.; Chang, D.; Koong, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB